EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

25 September 2017
Sheraton Boston Hotel,
Boston

Product Valuation and Deal Structuring: Business Development Masterclass

Maximize your product valuation and deal structuring skills to gain the competitive advantage when negotiating a deal

An intensive one-day course prior to BioPharm America™ 2017

EBD Academy Infographic!

From a report commissioned by EBD Academy, this infographic shows the key challenges facing life science organizations.

August Webinar Recording Now Available!


Best Practices in the Development of Out-Licensing Presentations

This short informative webinar examined the various presentations you should develop to optimize your outreach plan and maximize your out-licensing activities. 

• Why multiple presentations are needed for successful out-licensing

• The three kinds of presentations and what they look like

• Examining the key difference between good and bad out-licensing presentations

Click here to watch the recorded webinar now!

Webinar recording available now!


Using Comparables in Technology Valuations

Our recent webinar focused on the use of comparables to aid in the valuation of technology assets, with specific examples from the biotech and pharma industry.

In this webinar you will learn:

  • What is a comparable?
  • How do comparables fit in with valuation methodologies?
  • Pros and cons of using comparables

Click here to watch the recorded webinar now!

Product Valuation and Deal Structuring: Business Development Masterclass

Overview

This intensive and in-depth course in product valuation and deal structuring will provide you with definitive advantages during future negotiations. 

During the course you will examine best practices for assessing and valuing assets with interactive case studies and group discussion. 

You will gain an insight into both the buy and sell perspective and how each arrives at their negotiating positions.   

Armed with the skills acquired in this course, you will have the confidence to calculate and negotiate the financial aspects of transactions involving the divestiture, transfer and acquisition of biopharm technology rights.

Key highlights and benefits
  • Examine valuation concepts and understand why valuations differ between similar technologies
  • Review valuation methods, techniques and factors to ensure you are estimating both risk and return adequately
  • Examine why valuations of the same asset may differ impacting on negotiations
  • Participate in group case studies from the point of view of the “buy-side” and the “sell-side” to gain an appreciation of challenges both parties encounter
  • Learn to forecast revenue using both patient and market data to accurately value an asset in preparation for negotiations

Buzz Sessions at BioPharm America 2017: delivered by EBD Academy

What is a Buzz Session?

Delivered by EBD Academy and developed in partnership with EBD Group – buzz sessions will provide attendees with take-away skills and knowledge that will benefit them while at the event and in their professional careers. All buzz sessions are designed to be concise, informative and engaging which creates a learning environment that is exciting to be a part of.

Benefits of attending a Buzz Session
  • Gain practical skills that can be implemented immediately at the EBD event
  • High intensity sessions designed to improve your skillset
  • Interactive - Learn from the expert and others attending the session
  • Concise and informative
Buzz Sessions: Where & When

Buzz Sessions will be held on Day 2 of BioPharm America; Wednesday 27 September.

Who should attend?


This is an intensive valuation course intended for the following professionals:

  • Senior Executives

  • Business Development Professionals

  • Evaluation and Assessment Professionals

  • Technology Transfer Managers

  • Valuation Experts

Direct valuation experience is not required; however, it will be helpful if participants have a general understanding of biotech and/or pharmaceutical product development phases, industry terminology, financial terminology, and exposure to using Microsoft Excel spreadsheets. Valuation experts will leave this class with new insights, sharper skills and the opportunity to have had in-depth discussions with other experts in the field.

EBD Academy offers immersive training to maximize successful partnering and accelerate your career progression.


Our training courses will equip you will the skills needed to advance your career as well as network with like-minded people in the pharma/biotech industry. 

See how you could benefit by taking an EBD Academy course in our introductory video by Managing Director, Rosie Bernard. >>>

About EBD Academy?


Born out of a partnership between EBD Group and Pharmaceutical Training International (PTI), EBD Academy provides highly specialized and immersive training that is committed to the personal progression and employability of professionals involved in pharma/biotech partnering. 

Working in partnership with EBD Group, our vision is to enhance key skills and competencies to maximize successful partnering and accelerate career progression. We aim to deliver enriched learning content that has been researched with industry to tackle industry challenges and eliminate skills gaps.